USD 1.47
(0.68%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | 381.43 Thousand USD | 58.16% |
2022 | 241.17 Thousand USD | 1108.67% |
2021 | 19.95 Thousand USD | -58.95% |
2020 | 48.61 Thousand USD | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 Q1 | 236.15 Thousand USD | -2.08% |
2023 Q2 | 236.15 Thousand USD | 0.0% |
2023 Q4 | 381.43 Thousand USD | 0.0% |
2022 Q3 | 241.17 Thousand USD | 153.51% |
2022 Q1 | 95.13 Thousand USD | 0.0% |
2022 Q2 | 95.13 Thousand USD | 0.0% |
2022 FY | 241.17 Thousand USD | 1108.67% |
2022 Q4 | 241.17 Thousand USD | 0.0% |
2021 FY | 19.95 Thousand USD | -58.95% |
2020 FY | 48.61 Thousand USD | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Acadia Healthcare Company, Inc. | 1.34 Billion USD | 99.972% |
Addus HomeCare Corporation | 124.13 Million USD | 99.693% |
AirSculpt Technologies, Inc. | 69.5 Million USD | 99.451% |
Amedisys, Inc. | 346.76 Million USD | 99.89% |
American Oncology Network, Inc. | 120.44 Million USD | 99.683% |
Astrana Health, Inc. | 296.26 Million USD | 99.871% |
Aveanna Healthcare Holdings Inc. | 1.27 Billion USD | 99.97% |
IMAC Holdings, Inc. | - USD | -Infinity% |
biote Corp. | 106.63 Million USD | 99.642% |
Cryo-Cell International, Inc. | 9.28 Million USD | 95.891% |
Cross Country Healthcare, Inc. | 2.66 Million USD | 85.676% |
COMPASS Pathways plc | 28.75 Million USD | 98.674% |
DocGo Inc. | 15.16 Million USD | 97.484% |
The Ensign Group, Inc. | 1.78 Billion USD | 99.979% |
Healthcare Services Group, Inc. | 11.23 Million USD | 96.605% |
InnovAge Holding Corp. | 100.49 Million USD | 99.62% |
Assure Holdings Corp. | 505 Thousand USD | 24.468% |
The Joint Corp. | 2 Million USD | 80.928% |
LifeStance Health Group, Inc. | 280.28 Million USD | 99.864% |
ModivCare Inc. | 983.75 Million USD | 99.961% |
NewGenIvf Group Limited | 118.97 Thousand USD | -220.594% |
Novo Integrated Sciences, Inc. | 1.75 Million USD | 78.31% |
Option Care Health, Inc. | 1.05 Billion USD | 99.964% |
P3 Health Partners Inc. | 108.31 Million USD | 99.648% |
P3 Health Partners Inc. | 108.31 Million USD | 99.648% |
The Pennant Group, Inc. | 312.51 Million USD | 99.878% |
Surgery Partners, Inc. | 2.03 Billion USD | 99.981% |
Syra Health Corp. Class A Common Stock | - USD | -Infinity% |
Talkspace, Inc. | - USD | -Infinity% |
Talkspace, Inc. | - USD | -Infinity% |
The Oncology Institute, Inc. | 86.82 Million USD | 99.561% |
The Oncology Institute, Inc. | 86.82 Million USD | 99.561% |